3 hot growth stocks for under £1

These three stocks are undervalued for the growth they offer, and you can buy them for less than £1.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Looking for cheap growth stocks? Here are three profitable businesses that look undervalued for the earnings growth they’re set to deliver. You can buy their shares today for under £1.

£100m target

AIM-listed Idox (LSE: IDOX) has a market cap of £269m at a share price of 66.5p. This supplier of software solutions and services to the UK public sector (and also to the wider corporate sector) has recently completed an £18.5m acquisition that will significantly expand its presence in the health and social care market.

The company is targetting £100m revenue “in the short-to-medium term” and I believe it could hit this target in 12-18 months. Based on an improving pre-tax profit margin and standard tax rate, I think we could see earnings per share (EPS) approaching 5p — 20% ahead of 2016’s 4.11p — for which growth you’re currently paying a price-to-earnings (P/E) multiple of 13.5.

Idox’s strategy is to supplement organic growth with acquisitions and, while acquisitions are never without risk, such a strategy can provide lucrative returns for investors if pursued in a disciplined manner. I believe the potential growth here is appealing enough to rate the shares a ‘buy’.

Double benefit

Severfield (LSE: SFR) is a main market company — listed in the FTSE SmallCap index — and has a market cap of £241m at a share price of 81p. It’s the largest structural steel business in the UK, supplying office buildings (such as the Shard), stadia (such as Liverpool’s Anfield), tunnels, bridges and so on.

European firms have become less competitive in bidding for UK work, thanks to the slump in sterling, and Severfield is enjoying the double benefit of seeing “more opportunities” in Europe.

For its financial year ending 31 March, I’m expecting the company to post EPS of a little over 5p — 37% ahead of last year’s 3.67p — for which growth you’re currently paying a P/E multiple of 16. This is another stock that looks very buyable to me.

Packing a punch

Macfarlane (LSE: MACF) is a constituent of the FTSE Fledgling index (main market companies that are too small to be included in the FTSE All-Share). Its market cap is £85m at a share price of 62p.

The Glasgow-based firm is engaged in designing, manufacturing and distributing protective packaging materials in the UK, as well as adhesive and resealable labels for fast-moving-consumer-goods customers in the UK, Europe and the US.

Like Idox, Macfarlane is pursuing a strategy to supplement organic growth with acquisitions, further cementing its packaging materials UK distribution leadership in what is a highly fragmented market. I’m expecting EPS of 5.5p (26% ahead of the previous year’s 4.37p) when the company posts its 2016 results a week on Thursday. For this growth you’re currently paying a P/E multiple of just 11.3. As you might have guessed, I rate this stock a ‘buy’ too.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

3 super-reliable FTSE 100 stocks to consider buying for passive income in 2025

Our writer has been scanning the FTSE 100 for the best stocks to consider buying for the passive income they…

Read more »

Investing Articles

3 ISA strategies to consider for 2025

It's nearly New Year. And after that, ISA deadline time will start creeping up on us. It can pay to…

Read more »

The flag of the United States of America flying in front of the Capitol building
US Stock

The Nasdaq’s almost doubled in the past 2 years! Here’s what I think happens next

Jon Smith explains why the Nasdaq's done so well recently and flags up a specific stock he thinks could keep…

Read more »

Investing Articles

I’m ready for a stock market crash in 2025

Our writer highlights a high-quality FTSE 100 share that he'll buy instantly if the stock market has a major meltdown…

Read more »

Investing Articles

Up 10% in days, what on earth’s going on with the Diageo share price?

The Diageo share price has perked up in December. This shareholder takes a look at what's behind the Guinness maker's…

Read more »

Investing Articles

£20,000 in the FTSE All-Share at the start of 2024? Here’s what an investor would have now

Our writer looks at whether tracking the FTSE All-Share index has been a great investment this year. Spoiler: there's good…

Read more »

Investing Articles

Why I’ll be avoiding this FTSE 100 market darling in 2025

Ken Hall takes a look at one FTSE 100 stock that has been soaring higher in 2024, and why he…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Growth Shares

I’m taking Warren Buffett’s advice for when stocks are at record highs

Jon Smith looks back on some words of wisdom from Warren Buffett about how and where to invest as the…

Read more »